# Montelukast

NDC: 82009-009
Generic name: Montelukast
Labeler / Manufacturer: Quallent Pharmaceuticals Health LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220607

FDA application: ANDA202843

## Active ingredients

- MONTELUKAST SODIUM: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82009-009"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82009-009
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d71088b-b0fa-4bf0-a6e7-6163bd9e0dd4